Close

Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.

×

Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

Sanofi: Department of Justice ends FCPA probe

Jaclyn Jaeger | March 9, 2018

French pharmaceutical company Sanofi disclosed that the U.S. Department of Justice has closed its inquiry into allegations concerning potential violations of the U.S. Foreign Corrupt Practices Act.

In its Form 20-F, Sanofi said has been engaged in discussions with the Justice Department and the Securities and Exchange Commission “regarding allegations that certain subsidiaries outside the United States made improper payments in connection with the sale of pharmaceutical products and whether those payments, if made, fall within the U.S. Foreign Corrupt Practices Act.”

Sanofi said it voluntarily provided information to these agencies and “proactively cooperated in both agencies’ review of the allegations.”

The company added that it was notified by the Justice Department in February 2018 that the agency decided to close its inquiry into the allegations. Sanofi said it...

Read this single article for $49, or click the subscribe button below to review subscription options.

Enjoy unlimited access to thousands of articles, browse five years of digital magazines, qualify for reduced admission to events, and more.